Sort by
Refine Your Search
-
) technology with innovative biomaterial systems and cell therapy approaches. The successful candidate will join a dynamic research team with extensive expertise in RNA biology, drug delivery, and translational
-
for the development of next-generation CAR T cell therapy for solid tumours. You will work with a wide range of methods, including molecular biology, culture of human T cells, CRISPR multiplexed genome engineering
-
interactions. Clone and express top candidates using high-throughput cell-free and bacterial systems. Perform structural and biophysical characterisation of designed enzymes Perform functional characterisation
-
wound healing. Under the supervision of Asst. Prof. Konstantinos Kalogeropoulos and Assoc. Prof. Erwin Schoof, the PhD candidate will join the Protease Systems Biology group embedded in the Cell Diversity
-
, and fibrosis. Aberrant MMP activity can drive tissue destruction, pathological remodeling, and disrupted cell signaling, making them critical yet complex targets for therapeutic intervention. Despite
-
be compliant with the MSCA mobility rule: not have resided or carried out your main activity (work/study) in Denmark for more than 12 months in the 3 years immediately prior to recruitment. You are
-
management, self-organization and strong social skills. Lastly, you are expected to communicate scientific findings in international conferences as well as in high-impact scientific journals. Your primary
-
. You can communicate scientific topics clearly and effectively to both experts and non-specialists. Proficiency in English is required. You must be compliant with MSCA mobility rule: not have resided